Impact of adverse drug reactions on the outcomes of tuberculosis treatment

Detalhes bibliográficos
Autor(a) principal: Sant´Anna, Flávia M.
Data de Publicação: 2023
Outros Autores: Araújo-Pereira, Mariana, Schmaltz, Carolina A. S., Arriaga, María B., Andrade, Bruno B., Rolla, Valeria C.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/58411
Resumo: This work was supported by Brazilian Program of STD-AIDS and Viral Hepatitis, in partnership with the UNODC and the Clinical Research Laboratory on Mycobacteria of INI, FIOCRUZ, edital modalidade pesquisas n˚ 01/2013. The study was partially supported by the Intramural Research Program of the Fundação Oswaldo Cruz. B.B.A and V.C.R. are senior scientists from the Conselho Nacional de Desenvolvimento Cientı´fico e Tecnolo´gico (CNPq). M.B.A. received a scholarship from Fundação de Amparo à Pesquisa do Estado da Bahia (FAPESB). M.A.P. received a research fellowship from the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES, finance code: 001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript
id CRUZ_089db61fcbd822b599c51555e3809c55
oai_identifier_str oai:www.arca.fiocruz.br:icict/58411
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Sant´Anna, Flávia M.Araújo-Pereira, MarianaSchmaltz, Carolina A. S.Arriaga, María B.Andrade, Bruno B.Rolla, Valeria C.2023-05-15T23:57:26Z2023-05-15T23:57:26Z2023SANT'ANN, Flávia M. et al. Impact of adverse drug reactions on the outcomes of tuberculosis treatment. PLoS One, v. 18, n. 2, p. 1-14, Feb. 2023.1932-6203https://www.arca.fiocruz.br/handle/icict/5841110.1371/journal.pone.02697651932-6203This work was supported by Brazilian Program of STD-AIDS and Viral Hepatitis, in partnership with the UNODC and the Clinical Research Laboratory on Mycobacteria of INI, FIOCRUZ, edital modalidade pesquisas n˚ 01/2013. The study was partially supported by the Intramural Research Program of the Fundação Oswaldo Cruz. B.B.A and V.C.R. are senior scientists from the Conselho Nacional de Desenvolvimento Cientı´fico e Tecnolo´gico (CNPq). M.B.A. received a scholarship from Fundação de Amparo à Pesquisa do Estado da Bahia (FAPESB). M.A.P. received a research fellowship from the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES, finance code: 001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscriptOswaldo Cruz Foundation. National Institute of Infectious Diseases Evandro Chagas. Postgraduate Program Clinical Research in Infectious Diseases. Rio de Janeiro, RJ, Brazil / Oswaldo Cruz Foundation. National Institute of Infectious Diseases Evandro Chagas. Clinical Research Laboratory on Mycobacteria, (LAPCLIN-TB). Rio de Janeiro, RJ, Brazil.Federal University of Bahia. School of Medicine. Salvador, BA, Brazil / Multinational Organization Network Sponsoring Translational and Epidemiological Research Initiative. Salvador, BA, Brazil / Oswaldo Cruz Foundation. Gonçalo Moniz Institute. Laboratory of Inflammation and Biomarkers. Salvador, BA, Brazil.Oswaldo Cruz Foundation. National Institute of Infectious Diseases Evandro Chagas. Clinical Research Laboratory on Mycobacteria, (LAPCLIN-TB). Rio de Janeiro, RJ, Brazil.Federal University of Bahia. School of Medicine. Salvador, BA, Brazil / Multinational Organization Network Sponsoring Translational and Epidemiological Research Initiative. Salvador, BA, Brazil / Oswaldo Cruz Foundation. Gonçalo Moniz Institute. Laboratory of Inflammation and Biomarkers. Salvador, BA, Brazil.Federal University of Bahia. School of Medicine. Salvador, BA, Brazil / Multinational Organization Network Sponsoring Translational and Epidemiological Research Initiative. Salvador, BA, Brazil / Oswaldo Cruz Foundation. Gonçalo Moniz Institute. Laboratory of Inflammation and Biomarkers. Salvador, BA, Brazil / Escola Bahiana de Medicina e Saúde Pública. Curso de Medicina. Salvador, BA, Brazil / Universidade Salvador. Laureate Universities. Curso de Medicina. Salvador, BA, Brazil.Oswaldo Cruz Foundation. National Institute of Infectious Diseases Evandro Chagas. Postgraduate Program Clinical Research in Infectious Diseases. Rio de Janeiro, RJ, Brazil / Oswaldo Cruz Foundation. National Institute of Infectious Diseases Evandro Chagas. Clinical Research Laboratory on Mycobacteria, (LAPCLIN-TB). Rio de Janeiro, RJ, Brazil.Background: Adverse drug reactions (ADR) challenge successful anti-tuberculosis treatment (ATT). The aim of this study was to evaluate the impact of ATT-associated ADR and related factors on ATT outcomes. Methods: A prospective cohort study of persons with tuberculosis (TB) at a referral center in Rio de Janeiro, Brazil, from 2010 to 2016. Baseline information: race, sex, schooling, economic status, tobacco, drugs and alcohol abuse, HIV-infection status and comorbidities were captured during TB screening and diagnosis. Laboratory exams were performed to confirm TB diagnosis and monitor ADRs, favorable (cure and treatment completion) and unfavorable (death, loss to follow up and failure) outcomes were prospectively captured. The Kaplan-Meier curve was used to estimate the probability of ADR-free time. A logistic regression analysis (backward elimination) was performed to identify independent associations with unfavorable outcomes. Results: 550 patients were enrolled, 35.1% were people living with HIV (PLHIV) and ADR occurred in 78.6% of all participants. Smoking (OR: 2.32; 95% CI:1.34-3.99) and illicit-drug use (OR:2.02; 95% CI:1.15-3.55) were independent risk factors for unfavorable outcomes. In PLHIV, alcohol abuse and previous ART use were associated with unfavorable outcomes. In contrast, ADR increased the odds of favorable outcomes in the overall population. PLHIV more frequently experienced grade 3/4-ADR (18.36%), especially "liver and biliary system disorders". Lower CD4 counts (<100 cells/uL) were associated with hepatotoxicity (p = 0.03). ART-naïve participants presented a higher incidence of ADR in comparison with ART-experienced patients. Conclusion: Substance use was associated with unfavorable outcomes, highlighting the need for better strategies to reduce this habit. In contrast, ADRs were associated with favorable outcomes. Attention to the occurrence of ADR in PLHIV is essential, especially regarding hepatotoxicity in those with high immunosuppression.engPublic Library of ScienceImpact of adverse drug reactions on the outcomes of tuberculosis treatmentinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleTuberculosisAdverse drug reactions (ADR)Cohort studyHIVAnti-tuberculosis treatment (ATT)info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZORIGINALve_SantAnna_Flávia_etal_INI_2023.pdfve_SantAnna_Flávia_etal_INI_2023.pdfapplication/pdf1049497https://www.arca.fiocruz.br/bitstream/icict/58411/2/ve_SantAnna_Fl%c3%a1via_etal_INI_2023.pdf515879256c12cf2e30abbe3cad49c8acMD52LICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/58411/1/license.txt5a560609d32a3863062d77ff32785d58MD51icict/584112023-05-15 20:57:26.664oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-05-15T23:57:26Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.en_US.fl_str_mv Impact of adverse drug reactions on the outcomes of tuberculosis treatment
title Impact of adverse drug reactions on the outcomes of tuberculosis treatment
spellingShingle Impact of adverse drug reactions on the outcomes of tuberculosis treatment
Sant´Anna, Flávia M.
Tuberculosis
Adverse drug reactions (ADR)
Cohort study
HIV
Anti-tuberculosis treatment (ATT)
title_short Impact of adverse drug reactions on the outcomes of tuberculosis treatment
title_full Impact of adverse drug reactions on the outcomes of tuberculosis treatment
title_fullStr Impact of adverse drug reactions on the outcomes of tuberculosis treatment
title_full_unstemmed Impact of adverse drug reactions on the outcomes of tuberculosis treatment
title_sort Impact of adverse drug reactions on the outcomes of tuberculosis treatment
author Sant´Anna, Flávia M.
author_facet Sant´Anna, Flávia M.
Araújo-Pereira, Mariana
Schmaltz, Carolina A. S.
Arriaga, María B.
Andrade, Bruno B.
Rolla, Valeria C.
author_role author
author2 Araújo-Pereira, Mariana
Schmaltz, Carolina A. S.
Arriaga, María B.
Andrade, Bruno B.
Rolla, Valeria C.
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Sant´Anna, Flávia M.
Araújo-Pereira, Mariana
Schmaltz, Carolina A. S.
Arriaga, María B.
Andrade, Bruno B.
Rolla, Valeria C.
dc.subject.en.en_US.fl_str_mv Tuberculosis
Adverse drug reactions (ADR)
Cohort study
HIV
Anti-tuberculosis treatment (ATT)
topic Tuberculosis
Adverse drug reactions (ADR)
Cohort study
HIV
Anti-tuberculosis treatment (ATT)
description This work was supported by Brazilian Program of STD-AIDS and Viral Hepatitis, in partnership with the UNODC and the Clinical Research Laboratory on Mycobacteria of INI, FIOCRUZ, edital modalidade pesquisas n˚ 01/2013. The study was partially supported by the Intramural Research Program of the Fundação Oswaldo Cruz. B.B.A and V.C.R. are senior scientists from the Conselho Nacional de Desenvolvimento Cientı´fico e Tecnolo´gico (CNPq). M.B.A. received a scholarship from Fundação de Amparo à Pesquisa do Estado da Bahia (FAPESB). M.A.P. received a research fellowship from the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES, finance code: 001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript
publishDate 2023
dc.date.accessioned.fl_str_mv 2023-05-15T23:57:26Z
dc.date.available.fl_str_mv 2023-05-15T23:57:26Z
dc.date.issued.fl_str_mv 2023
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv SANT'ANN, Flávia M. et al. Impact of adverse drug reactions on the outcomes of tuberculosis treatment. PLoS One, v. 18, n. 2, p. 1-14, Feb. 2023.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/58411
dc.identifier.issn.en_US.fl_str_mv 1932-6203
dc.identifier.doi.none.fl_str_mv 10.1371/journal.pone.0269765
dc.identifier.eissn.none.fl_str_mv 1932-6203
identifier_str_mv SANT'ANN, Flávia M. et al. Impact of adverse drug reactions on the outcomes of tuberculosis treatment. PLoS One, v. 18, n. 2, p. 1-14, Feb. 2023.
1932-6203
10.1371/journal.pone.0269765
url https://www.arca.fiocruz.br/handle/icict/58411
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Public Library of Science
publisher.none.fl_str_mv Public Library of Science
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/58411/2/ve_SantAnna_Fl%c3%a1via_etal_INI_2023.pdf
https://www.arca.fiocruz.br/bitstream/icict/58411/1/license.txt
bitstream.checksum.fl_str_mv 515879256c12cf2e30abbe3cad49c8ac
5a560609d32a3863062d77ff32785d58
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1798324829445685248

Registros relacionados